Sunshine Biopharma Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	0.05M	0.09M	0.12M	0.15M	0.13M	3.94M	4.89M	5.56M	5.96M	7.68M	7.54M	9.30M	8.44M	9.59M	8.90M	9.41M	9.42M	8.58M	8.09M	9.26M
Cost of Revenue (Quarter)	0.02M	0.06M	0.06M	0.09M	0.07M	2.25M	0.13M	3.61M	0.24M	0.23M	0.20M	0.26M	0.28M	-16.76M	0.40M	5.99M	0.24M	5.55M	0.25M	6.84M
Gross Profit (Quarter)	0.03M	0.02M	0.06M	0.08M	0.07M	1.49M	1.83M	1.95M	1.99M	2.57M	2.35M	2.36M	2.87M	3.09M	2.73M	3.42M	3.07M	3.03M	2.18M	2.43M
Operating items
Research & Development (Quarter)	0.22M	0.09M	0.36M	0.05M	0.36M	0.04M	0.43M	0.37M	0.24M	0.82M	0.22M	0.44M	0.13M	0.15M	0.22M	0.20M	0.12M	0.07M	0.03M	0.01M
Selling, General & Administrative (Quarter)	0.53M	0.30M	1.29M	0.77M	1.79M	24.85M	3.66M	2.97M	2.77M	3.76M	3.70M	3.62M	3.97M	5.13M	4.03M	5.48M	4.16M	4.82M	3.58M	4.04M
Restructuring Costs (Quarter)									0.54M	0.72M	0.91M	0.71M	0.53M	0.91M	0.93M	0.81M	0.61M	1.52M	0.87M	0.76M
Other Operating Expenses (Quarter)																	-0.01M	-7.00
Operating Expenses (Quarter)	0.75M	0.39M	1.65M	0.82M	2.15M	24.90M	4.09M	3.34M	3.55M	5.29M	4.84M	4.77M	4.63M	6.19M	5.17M	6.48M	4.89M	6.41M	4.48M	4.81M
Operating Income (Quarter)	-0.50M	-0.28M	-1.22M	-0.70M	-1.72M	-23.36M	-1.83M	-1.01M	-0.78M	-1.19M	-1.35M	-1.27M	-1.11M	-2.04M	-1.30M	-2.05M	-1.09M	-1.79M	-1.40M	-1.61M
EBIT (Quarter)	-0.50M	-0.28M	-1.22M	-0.70M	-1.72M	-23.36M	-1.83M	-1.01M	-0.78M	-1.19M	-1.35M	-1.27M	-1.11M	-2.04M	-1.30M	-2.05M	-1.09M	-1.79M	-1.40M	-1.61M
Non-operating items
Non Operating Interest Expenses (Quarter)			0.10M	0.09M	0.22M
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)																0.07M				0.05M
Other Non Operating Income (Quarter)	0.01M	19.00	-9.00	0.01M	25.00	-521.00	15.00	-261.00	40.00	-39.00	-0.01M	0.29M	0.02M	-0.34M	451.00	0.00M	253.00	-2.00	-18.00	-6.00
Non Operating Income (Quarter)	-3.54M	0.95M	-0.01M	0.16M	0.26M	0.08M	0.17M	0.20M	0.17M	0.16M	0.09M	0.43M	0.12M	-0.25M	0.08M	0.07M	0.07M	0.06M	0.15M	0.05M
Net income details
EBT (Quarter)	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.28M	-1.66M	-0.81M	-0.61M	-1.03M	-1.26M	-0.84M	-0.98M	-2.29M	-1.22M	-1.98M	-1.02M	-1.73M	-1.24M	-1.56M
Tax Provisions (Quarter)						0.23M	0.05M	0.09M	0.05M	0.18M	0.02M	0.15M	0.22M	0.26M	-0.04M	-0.21M	-0.14M	0.43M
Profit After Tax (Quarter)	-4.04M	0.83M	-1.24M	-0.55M	-1.50M	-23.33M	-1.69M	-0.41M	-1.11M	-0.76M	-1.83M	-1.33M	-0.35M	-1.63M	-1.15M	-1.77M	-1.49M	-2.65M	-1.52M	-1.88M
Income from Continuing Operations (Quarter)	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.66M	-1.21M	-1.28M	-0.98M	-1.20M	-2.54M	-1.18M	-1.77M	-0.88M	-2.16M	-1.24M	-1.56M
Consolidated Net Income (Quarter)	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.66M	-1.21M	-1.28M	-0.98M	-1.20M	-2.54M	-1.18M	-1.77M	-0.88M	-2.16M	-1.24M	-1.56M
Income towards Parent Company (Quarter)	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.66M	-1.21M	-1.28M	-0.98M	-1.20M	-2.54M	-1.18M	-1.77M	-0.88M	-2.16M	-1.24M	-1.56M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-4.04M	0.67M	-1.24M	-0.54M	-1.46M	-23.51M	-1.70M	-0.90M	-0.65M	-1.21M	-1.28M	-1.78M	-1.20M	-2.16M	-1.18M	-2.95M	0.30M	-2.14M	-1.24M	-1.56M
Additional items
EPS (Basic) (Quarter)	-0.03M	0.01M	-0.00M	-680.39	-0.00M	-0.03M	-0.00M	-711.44	-506.99	-995.87	-400.31	-357.55	-9.45	-30.75	-4.36	-6.56	0.65	-5.15	-2.54	-1.15
EPS (Diluted) (Quarter)		0.01M	-0.00M	-680.39	-0.00M	-0.03M	-0.00M	-711.44	-506.99	-995.87	-400.31	-357.55	-9.45	-30.75	-4.36	-8.19	0.75	-5.45	-3.17	-3.98
Shares Outstanding (Quarter)	127.00	131.00	264.00	792.00	944.00	759.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.13M	0.07M	0.27M	0.45M	0.46M	0.42M	0.49M	1.37M
Shares Outstanding (Diluted) (Quarter)		131.00	264.00	792.00	944.00	759.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.13M	0.07M	0.27M	0.36M	0.39M	0.39M	0.39M	0.39M
Shares Outstanding (Entity) (Quarter)	128.00	130.00	264.00	944.00	944.00	759.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.13M	0.07M	0.27M	0.46M	0.46M	0.49M	0.49M	1.37M
EBITDA (Quarter)	-0.50M	-0.28M	-1.22M	-0.70M	-1.72M	-23.36M	-1.83M	-1.01M	-0.78M	-1.19M	-1.35M	-1.27M	-1.11M	-2.04M	-1.30M	-2.05M	-1.09M	-1.79M	-1.40M	-1.61M
Interest Expenses (Quarter)	0.05M	-0.12M	0.02M		2.00	-0.01M	0.10M	0.11M	0.11M	0.03M	0.10M	0.10M	0.10M	0.01M	0.18M	0.19M	0.19M		0.18M	0.18M
Tax Rate (Quarter)						-1.00%	-2.79%	-10.77%	-8.61%	-17.69%	-1.77%	-17.40%	-21.90%	-11.17%	3.29%	10.56%	13.46%	-24.89%

Research Tools

Datasets

Plans

Developers

Sunshine Biopharma SBFM Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Sunshine Biopharma SBFM Income Statement (2010-2026)

Create an account

Sign In

Reset Password